Metrics as of 10/14/2026, 08:43 AM (Berlin time), refresh in progress.
PolyPeptide Group Stock
PolyPeptide Group AG
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Switzerland
- CEO
- Juan Jose Gonzalez
- Employees
- 1,460
- Market cap
- CHF1.5 B
- IPO
- 28/04/2021
PolyPeptide Group AG operates globally as a contract development and manufacturing organization (CDMO) specializing in the production of Good Manufacturing Practice (GMP)-grade peptides. Headquartered in Baar, Switzerland, the company is listed on the SIX Swiss Exchange. Its core business involves providing both…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
PolyPeptide Group stock: price history
1D
+0.8%
1W
+0.6%
1M
+0.6%
6M
+18.1%
YTD
+69.7%
1Y
+81.2%
2Y
+64.1%
5Y
-59.7%
10Y
–
Next earnings date
Next earnings date
09/03/2027 (in 143 days)
Volatility around earnings
~47% stronger price swings than usual
Ask the agents about PolyPeptide Group
PolyPeptide Group stock metrics
P/E
110.43
P/B
4.45
EV/EBITDA
20.85
RETURN ON EQUITY
2.6%
NET MARGIN
3.8%
DEBT/EQUITY
0.4
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
39.3%
FLOAT SHARES
12,958,047
AVG. DAILY VOLUME (30D)
88,950
Dividends
Comparable stocks
Frequently asked questions about PolyPeptide Group stock
What does PolyPeptide Group do?
PolyPeptide Group AG is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Switzerland.
The CEO is Juan Jose Gonzalez, the company employs around 1,460 people.
The IPO was on 28/04/2021; the stock trades on SIX under the ticker PPGN.SW.
When does PolyPeptide Group report next?
The next earnings date is 09/03/2027.
Around past earnings, price swings were roughly 47% stronger than usual.
Does PolyPeptide Group pay a dividend?
Yes. The last dividend was CHF 0.30 per share, ex-date 28/04/2022, paid on 02/05/2022.
The dividend yield is 0.0% (as of 30/06/2026).
Which stocks are comparable to PolyPeptide Group?
Comparable stocks include Sandoz Group, Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
How can I get PolyPeptide Group stock analyzed?
Clicking "Analyze stock" lets five strategies assess PolyPeptide Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.